Adaptive SABR Boost Shows Promise in Advanced NSCLC

Radiation dose-escalation combined with stereotactic ablative radiotherapy may improve locoregional control in patients with NSCLC.

Related Keywords

California ,United States ,Los Angeles ,Trudyc Wu ,University Of California ,Lung Cancer ,Ung Carcinoma ,Ancer Of The Lung ,Non Small Cell Lung Cancer ,Nsclc ,Radiation Dose ,Radiation Therapy ,Radiotherapy ,Radiation Oncology ,Biologic Therapy ,Iologics ,Immunotherapy ,Small Cell Lung Cancer ,At Cell Lung Cancer ,Clc ,A Scan Biometry ,A Scan Ultrasound Biometry ,Ea Scan ,Cancer ,Alignant Neoplasia ,Arcinoma ,Alignant Neoplasm ,Lung ,